RespireRx Pharmaceuticals Inc. - FORM S-1 - EX-23.1 - CONSENT OF HASKELL & WHITE LLP - January 20, 2011

Attached files

file filename
S-1 - FORM S-1 - RespireRx Pharmaceuticals Inc.ds1.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - RespireRx Pharmaceuticals Inc.dex21.htm
EX-5.1 - OPINION OF STRADLING YOCCA CARLSON & RAUTH - RespireRx Pharmaceuticals Inc.dex51.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in the Registration Statement of Cortex Pharmaceuticals, Inc. on Form S-1, of our report dated April 7, 2010 appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to us under the heading “Experts” in this Registration Statement.

 

/s/ Haskell & White LLP
HASKELL & WHITE LLP

Irvine, California

January 19, 2011

RespireRx Pharmaceuticals Inc. Reports